Hypothesis: Inserting bacterial natural transformation protein complexes into human cells for efficient gene therapy using naked DNA by Tolmachov, O
Article ID: WMC00577
Hypothesis: Inserting bacterial natural
transformation protein complexes into human cells
for efficient gene therapy using naked DNA
Author(s):Dr. Oleg Tolmachov
Corresponding Author:
Dr. Oleg Tolmachov,
Research Associate, National Heart and Lung Institute, Imperial College London, Sir Alexander Fleming Building,
SW7 2AZ - United Kingdom
Submitting Author:
Dr. Oleg Tolmachov,
Research Associate, National Heart and Lung Institute, Imperial College London, Sir Alexander Fleming Building,
SW7 2AZ - United Kingdom
Article ID: WMC00577
Article Type: My opinion
Submitted on:09-Sep-2010, 03:07:12 PM GMT    Published on: 09-Sep-2010, 09:08:41 PM GMT
Article URL: http://www.webmedcentral.com//article_view/577
Subject Categories:HUMAN GENETICS
Keywords:transfection methods, non-viral gene transfer, naked DNA vectors, gene therapy, natural
transformation, gene delivery
How to cite the article:Tolmachov O. Hypothesis: Inserting bacterial natural transformation protein complexes
into human cells for efficient gene therapy using naked DNA . WebmedCentral HUMAN GENETICS
2010;1(9):WMC00577
Source(s) of Funding:
The article is funded by the author
Competing Interests:
The author does not have any competing interests to declare
Webmedcentral > My opinion Page 1 of 6
WMC00577 Downloaded from http://www.webmedcentral.com on 09-Sep-2010, 09:08:43 PM
Hypothesis: Inserting bacterial natural
transformation protein complexes into human cells
for efficient gene therapy using naked DNA
Abstract
Naked DNA is a non-toxic vector for therapeutic gene
delivery. However, current methods of transfection
with naked DNA reach a limited range of susceptible
tissues and have a low efficiency. The transfection of
clinically important post-mitotic cells is particularly
challenging because in these cells DNA need to pass
the nuclear barrier.  Thus, new principles for the
transfer of naked DNA into human cells are required
and can be found among the genetic exchange
mechanisms in bacteria, where gene entry into cells
via pick-up and transfer of naked DNA is known as
“transformation”. In a number of bacteria, dedicated
molecular machinery facilitates cell entry of free DNA
by the process of “natural transformation”. In
transformation-competent bacterial cells, specialised
protein complexes mediate the binding of free
double-stranded DNA, its fragmentation, cell entry and
conversion to single-stranded DNA. I propose to
exploit bacterial natural transformation machinery for a
two-step transfection of human cells with therapeutic
naked DNA. Firstly, the bacterial transformation
protein complexes are inserted into the plasma
membranes or nuclear envelopes of the target human
cells and, secondly, the double-stranded vector DNA
is supplied for the processing by the installed DNA
transfer apparatus. I hypothesize that non-toxic
bacterial transformation complexes residing in their
new human milieu can promote the ultra-efficient
transfer of exogenous therapeutic naked DNA. As the
introduction of DNA into mammalian cells by non-viral
means is called “transfection”, I propose to name the
bacterial transformation complexes functioning in their
new eukaryotic surroundings as “transfectosomes”.
The initial step of the gene delivery should exploit the
modern methods of extraneous protein insertion into
mammalian cells, such as cell painting, engineering of
cell permeable proteins with targeted intracellular
localization, physical techniques of protein transfer like
e l e c t r o i n s e r t i o n  a n d  e l e c t r o p o r a t i o n .
Sequence-selective natural transformation systems
are known and can be taken advantage of to exclude
undesired (e.g. gene silencing) portions of vector DNA
from entering human nucleoplasm. Improved
transfectosomes can possibly be engineered for better
establishment and performance in human membranes.
The hypothesis can be tested by comparing the naked
D N A  t r a n s f e r  e f f i c i e n c y  i n t o  t h e
transfectosome-bearing and the naive human cells in
ex-vivo  and in-vivo  gene therapy sett ings.
Immunogenicity of the transfectosomes can be
modulated by protein engineering. As the delivered
fragments of single-stranded DNA are highly
recombinogenic, the confirmation of the hypothesis
can lead to a breakthrough in gene repair therapy of
dominantly inherited familial hypercholesterolemia,
polycystic kidney disease and trinucleotide repeat
disorders.
Background
Gene therapy is achieved by the transfer of genetic
material to human cells and subsequent correction of
the disease-causing faulty genes or expression of
therapeutic transgenes. Genetic material can be
delivered after packaging into virions, complexing with
transfer-promoting substances or as naked DNA.
Transfection with naked DNA is an attractive gene
therapy approach because of pure DNA’s lack of
toxicity. It was discovered that some tissues (e.g.
skeletal muscle, heart muscle, thyroid, solid tumours)
are capable of pure DNA uptake after a simple
injection, although with a low efficiency [1]. Physical
methods of pure DNA delivery like high-volume
high-pressure “hydrodynamic”  in ject ion,
electroporation, microbubble-assisted sonoporation
and jet-injection can broaden the spectrum of the
susceptible tissues and increase the efficiency of gene
delivery [2, 3]. However, further improvements in
naked DNA transfer technology are needed to foster
therapeutic applications.
 
Common therapeutic targets are non-dividing or
rarely-dividing human cells where, in addition to the
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external plasma membrane, the inward bound vector
DNA need to pass through the nuclear envelope
barrier in order to reach its destination in the
nucleoplasm. There is no evidence that the currently
available procedures can provide efficient transfer of
naked DNA to nuclei. Normally, the delivery of genes
into postmitotic cells requires transduction with some
viral vectors or transfection involving the complexing of
DNA with nuclear transfer promoting substances [4, 5].
These nuclear transfer methods suffer from high
toxicity. Therefore, new principles for the transfer of
naked DNA into human cells are required.
 
In search of such principles one can look at the
genetic exchange mechanisms in bacteria, where
gene entry into cells via pick-up and transfer of naked
DNA is known as “transformation”. Some bacterial
species developed in their evolution a process of
“natural  t ransformat ion” wi th special ised
transformation protein complexes, which reside in the
bacterial membranes, mediating the binding of
extraneous double-stranded DNA, its fragmentation,
cell entry and conversion to a highly recombinogenic
single-stranded form [6, 7]. Natural bacterial
transformation systems are known in Gram-positive
genera Bacillus and Streptococcus, Gram-negative
genera Acinetobacter, Haemophilus, Helicobacter,
Neisseria, Pseudomonas and many others. In all
well-studied cases transformation complexes are
discrete self-assembled membrane-associated protein
ensembles. Transformation complexes can be
composed of integral membrane proteins (e.g.
secretins), traffic NTPases and structural proteins like
pil ins. The particular details of the natural
transformation machinery vary between various
bacterial species, especially between Gram-positive
and Gram-negative bacteria, which have disparate cell
wall  structures. Port ions of such bacterial
transformation protein complexes are sometimes
observable microscopically and are called
“transformosomes” in Haemophilus influenza.
The hypothesis
I propose to exploit bacterial natural transformation
machinery for a two-step transfection of human cells
with therapeutic naked DNA. Firstly, the bacterial
transformation protein complexes are inserted into the
plasma membranes or nuclear envelopes of the target
human cells and, secondly, the double-stranded vector
DNA is supplied for the processing by the installed
DNA transfer apparatus. I hypothesize that non-toxic
bacterial transformation complexes residing in their
new human milieu can promote the ultra-efficient
transfer of exogenous therapeutic naked DNA. As the
introduction of DNA into mammalian cells by non-viral
means is called transfection, I propose to name
functional bacterial transformation complexes in their
new eukaryotic setting as “transfectosomes”. Improved
transfectosomes can possibly be engineered offering
better establishment and performance in human
membranes providing for both efficient gene repair
and therapeutic transgene expression. Protein
engineer ing can a lso be used to  reduce
immunogenicity of transfectosomes, if required.
Evaluation of the hypothesis
Transformation protein complexes can be harvested
from their original host bacteria. If the competent state
of the bacteria is not constitutive, it should be induced
prior to the harvesting of the transformation complexes.
Alternatively, individual proteins for the transformation
complexes can be expressed in heterologous bacteria,
yeast, insect or plant cells. In this case self-assembly
of the complexes can be accomplished either
immediately in the producer cells, or with purified
proteins in vitro, or after insertion into the human cells.
 Transformation complexes from various bacterial
species should be compared to find the most suitable
foundation for the generation of transfectosomes with
the best performance in the human membrane setting.
The select ion cr i ter ia might a lso include
non-pathogenicity of the bacterial host, which could
simplify the complexes’ production. Mutant versions of
the transformation ensembles with an increased
efficiency of DNA transfer can be selected in their
native bacterial background or in cells of heterologous
organisms.
 
The absence of a rigid cell wall in mammalian cells
allows unobstructed insertion of proteins and protein
complexes into the plasma membrane of the cells.
Integral membrane proteins and their complexes can
be delivered to the human plasma membrane in a lipid
or detergent carrier by the procedure known as “cell
painting” [8-10] . Physical methods of protein transfer
like electroinsertion [11] and electroporation [12] can
also be employed for the protein delivery. Artificial
modification of natural transformation complexes might
be required to prepare effective transfectosomes
adapted to the correct establishment and DNA transfer
within mammalian plasma membrane milieu. For
e x a m p l e ,  p r o t e i n  m o d i f i c a t i o n  w i t h
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glycosyl-phosphatidylinositol (GPI) membrane anchors
and/or other lipidations can be used.  Glycosylated
derivatives of the transfectosome proteins can be
generated to provide a signal for the correct
orientation of the protein complex in the membrane.
The elements of the transformation complex and its
auxilliary proteins can be delivered into human
cytoplasm if supplied with a “protein transduction”
(PTD) domain, as successfully used for Cre
recombinase [13] and FLP recombinase [14]. A
combination of different protein delivery approaches
might be the optimal option.
 
Theoretically, it is possible to introduce bacterial
t ransgenes to d i rect  the b iosynthesis of
transfectosomes in human cells. However, the need
for transfectosomes is transient, and so the insertion
of “pre-made” proteins into human cells looks more
attractive than transfectosome biosynthesis in situ.
The protein delivery option benefits from the possibility
to modulate the self-assembly of the transformation
complexes in vitro, while the choice of the in situ
biosynthesis option might result in insertional
mutagenesis or potentially deleterious long-term
expression of bacterial transgenes in human cells.
Nevertheless, stable mammalian cell l ines
permanently or inducibly expressing transfectosomes
can be generated for ultra-efficient transfection needs,
e.g. for transgene expression studies, viral gene
vector production or gene repair research.
 
For efficient transfection of postmitotic cells, it would
be advantageous to insert bacterial transformation
complexes into the nuclear envelope to drive the
efficient transport of the DNA into the nucleoplasm. In
this scenario, the transformation complexes need to
be artificially modified to reach the nuclear envelope
and to acquire the functional state there. In particular,
bacterial transformation complexes should be supplied
with targeting signals for outer and inner nuclear
membranes [15, 16]. Under standard circumstances,
incoming DNA should be double-stranded prior to the
entry into bacterial transformation complexes and it is
expected to be single-stranded after being processed
by the complexes. Therefore, the concomitant
employment of the transfectosomes in plasma
membrane and nuclear envelope is complicated by the
requirement of either unusual cytoplasmic synthesis of
the second DNA strand or an essential modification of
the plasma membrane transfectosomes with a block of
conversion of the double-stranded DNA into the
single-stranded form.
 
Some systems of natural transformation are known for
their DNA sequence selectivity, e.g. competent cells of
Neisseria gonorrhoeae require 10-bp sequence
5’-GCCGTCTGAA-3’ to be present in the extraneous
DNA for eff ic ient cel l  incorporat ion. Such
sequence-specific transformation machinery can be
used for DNA transfer into human cells or nuclei,
provided the required sequence tags are inserted into
vector DNA. As the incoming DNA is fragmented by
the transformation machinery, the tagged portions of
exogenous DNA would be able to enter the cells while
the non-tagged DNA portions would be denied access.
This sequence-selectivity can be exploited for the
advantage of gene therapy. For example, as an origin
of replication and a marker gene of a bacterial plasmid,
used for gene delivery, were reported to induce
undesired transgene silencing [17],  the tag sequences
could be arranged to be excluded from the bacterial
plasmid backbone DNA sequences.
 
The hypothesis should be tested by experiments in
vitro and in vivo with view of ex-vivo and in-vivo gene
therapy. Human cells should be furnished with
transformation complexes with the excess extraneous
protein removed by washing or by epitope-targeted
immunoprecipitation to minimise the premature
binding of the transformation complexes and DNA.
Transfectosome-bearing cells should be incubated
with pure DNA and the efficiency of gene transfer
should be evaluated by standard methods relying on
the chromosome recombination events or transgene
expression in the treated cells. As an additional model
system, transformation complexes can be assembled
into proteoliposomes and the conditions for the DNA
transfer into their interior compartments can be studied.
 
The proposed bipartite transfection strategy is
expected to combine ultra-high efficiency of gene
delivery with the advantages of naked DNA vectors
because pure DNA would be used without complexing
by cytotoxic polycationic transfectants or packaging
into cytotoxic virions. The insertion of bacterial
transformation complexes into human cells is not likely
to be toxic. In many in-vivo gene therapy scenarios,
immune response associated with gene delivery is
detrimental. Thus, pre-existing immunity to the
transformation protein complexes should be avoided
by the thoughtful choice of the bacterial source for the
transformation complexes and their purposeful
re-engineering. The transfectosomes are required only
for a short period of time during DNA delivery and are
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likely to be degraded by the time a substantial immune
response is mounted against them. Conversely, in
gene therapy of cancer, immune response after gene
delivery is often beneficial, so in this situation, the
i m m u n o s t i m u l a t o r y  p o t e n t i a l  o f  t h e
transfectosome-insertion step should be taken
advantage of.
 
Once in the nucleoplasm, the single-stranded DNA
generated by the transfectosomes can be immediately
available for gene repair by strand displacement.
Alternatively, single-stranded DNA can be built up to
the double-stranded form in vivo and mediate
transgene expression. It is well-documented that
genes delivered as single-stranded DNA by
adeno-associated virus (AAV) vectors [18] and
filamentous bacteriophages [19] can be expressed in
mammalian cells. Nevertheless, the anticipated
fragmentation of DNA and its conversion to the
single-stranded form by transfectosomes might have a
negative effect on the expression of large therapeutic
transgenes. Therefore, gene correction treatment,
which can rely on smaller DNA fragments and which
can benefit from the highly recombinogenic status of
the single-stranded DNA, is a particularly attractive
application of the transfectosome-mediated gene
transfer. The confirmation of the hypothesis can lead
to a breakthrough in gene repair therapy of dominantly
inherited familial hypercholesterolemia, polycystic
kidney disease and trinucleotide repeat disorders,
such as Huntington’s disease.
Reference(s)
1.         Wolff JA, Budker V. The mechanism of naked
DNA uptake and expression. Adv Genet. 2005; 54:
3-20.
2.         Wells DJ. Electroporation and ultrasound
enhanced non-viral gene delivery in vitro and in vivo.
Cell Biol Toxicol. 26(1): 21-8.
3.         Kamimura K, Suda T, Xu W, Zhang G, Liu D.
Image-guided, lobe-specific hydrodynamic gene
delivery to swine liver. Mol Ther. 2009; 17(3): 491-9.
4.         Leclere PG, Panjwani A, Docherty R, Berry M,
Pizzey J, Tonge DA. Effective gene delivery to adult
neurons by a modified form of electroporation. J
Neurosci Methods. 2005; 142(1): 137-43.
5.         Vaysse L, Gregory LG, Harbottle RP, Perouzel
E, Tolmachov O, Coutelle C. Nuclear-targeted
minicircle to enhance gene transfer with non-viral
vectors in vitro and in vivo. J Gene Med. 2006; 8(6):
754-63.
6.         Claverys JP, Martin B, Polard P. The genetic
transformation machinery: composition, localization,
and mechanism. FEMS Microbiol Rev. 2009; 33(3):
643-56.
7.         Averhoff B, Friedrich A. Type IV pili-related
natural transformation systems: DNA transport in
mesophilic and thermophilic bacteria. Arch Microbiol.
2003; 180(6): 385-93.
8.         Premkumar DR, Fukuoka Y, Sevlever D,
Brunschwig E, Rosenberry TL, Tykocinski ML, et al.
Properties of exogenously added GPI-anchored
proteins following their incorporation into cells. J Cell
Biochem. 2001; 82(2): 234-45.
9.         Kato K, Itoh C, Yasukouchi T, Nagamune T.
Rapid protein anchoring into the membranes of
Mammalian cells using oleyl chain and poly(ethylene
glycol) derivatives. Biotechnol Prog. 2004; 20(3):
897-904.
10.       Liu S, Foster BA, Chen T, Zheng G, Chen A.
Modifying dendritic cells via protein transfer for
antitumor therapeutics. Clin Cancer Res. 2007; 13(1):
283-91.
11.       Raffy S, Lazdunski  C, Teissie J.
Electroinsertion and activation of the C-terminal
domain of colicin A, a voltage gated bacterial toxin,
into mammalian cell membranes. Mol Membr Biol.
2004; 21(4): 237-46.
12.       Lukas J, Bartek J, Strauss M. Efficient transfer
of antibodies into mammalian cells by electroporation.
J Immunol Methods. 1994; 170(2): 255-9.
13.       Lin Q, Jo D, Gebre-Amlak KD, Ruley HE.
Enhanced cell-permeant Cre protein for site-specific
recombination in cultured cells. BMC Biotechnol. 2004;
4: 25.
14.       Patsch C, Peitz M, Otte DM, Kesseler D,
Jungverdorben J, Wunderlich FT, et al. Engineering
Cell-Permeant FLP Recombinase for Tightly
Controlled Inducible and Reversible Overexpression in
Embryonic Stem Cells. Stem Cells. 2010; 28(5):
894-902.
15.       Lusk CP, Blobel G, King MC. Highway to the
inner nuclear membrane: rules for the road. Nat Rev
Mol Cell Biol. 2007; 8(5): 414-20.
16.       Kvam E, Goldfarb DS. Structure and function
of nucleus-vacuole junctions: outer-nuclear-membrane
targeting of Nvj1p and a role in tryptophan uptake. J
Cell Sci. 2006; 119(Pt 17): 3622-33.
17.       Chen ZY, Riu E, He CY, Xu H, Kay MA.
Webmedcentral > My opinion Page 5 of 6
WMC00577 Downloaded from http://www.webmedcentral.com on 09-Sep-2010, 09:08:43 PM
Silencing of episomal transgene expression in liver by
plasmid bacterial backbone DNA is independent of
CpG methylation. Mol Ther. 2008; 16(3): 548-56.
18.       Zhou X, Zeng X, Fan Z, Li C, McCown T,
Samulski RJ, et al. Adeno-associated virus of a
single-polarity DNA genome is capable of transduction
in vivo. Mol Ther. 2008; 16(3): 494-9.
19.       Larocca D, Jensen-Pergakes K, Burg MA,
Baird A. Gene transfer using targeted filamentous
bacteriophage. Methods Mol Biol. 2002; 185: 393-401.
Webmedcentral > My opinion Page 6 of 6
